Table 1.
Demographic and clinical characteristics of the study population
| Group IH (n = 14) | Group IF (n = 10) | |
|---|---|---|
| Age, y | 8 ± 3 | 11 ± 4 |
| Sex | ||
| Male intact | 5 | 5 |
| Male neuter | 3 | 3 |
| Female intact | 2 | 0 |
| Female neuter | 4 | 2 |
| History of hypertension (yes/no) | 5/9 | 8/2 |
| Mean systolic blood pressure (mm Hg) | 150.9 ± 16.6 | 157.0 ± 5766 |
| History of proteinuria (yes/no) | 14/0 | 10/0 |
| Median UPC (IQR) | 1.8 (1.5‐2.5) | 2.4 (1.9‐3.2) |
| Median WBC (IQR) | 8.8 (7.05‐10.58) | 7.9 (6.75‐10.53) |
| History of use of ACEis/CCB | 2/3 | 4/4 |
| History of the use of combined treatment (ACEi + CCB) (yes/no) | 5/9 | 2/8 |
| History of the use of phosphate binders (yes/no) | 14/0 | 10/0 |
| History of the use of EPO (yes/no) | 4/10 | 1/9 |
| History of the use of gastroprotectants (yes/no) | 14/0 | 10/0 |
Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; CCB, calcium channel blocker; EPO, erythropoietin; IF, IV fluid therapy; IH, intermittent hemodialysis; IQR, interquartile range; UPC, urinary protein:creatinine ratio.